Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 25

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 3
Chunk 25
---
or Management and Employees - C. Board Practices - 
Approval of Related Party Transactions under Israeli Law - Disclosure of Personal Interests of an Office Holder and Approval of Certain
Transactions.”

Compensation of Executive Officers

Our compensation for our executive officers is paid pursuant to
written employment agreements that we have entered with each of our executive officers and is based, in part, on each executive officer’s
personal contribution to our management, operations and success. Such compensation is determined consistent with our compensation policy.
For more information on our compensation policy, please see “ - Compensation Policy” above.

Each executive officer’s entitlement to an annual bonus is
determined according to a formula that links financial and qualitative target-based goals and metrics related to the specific objectives
within the responsibility of the relevant executive officer. In the case of executive officers who are also office holders, their annual
bonus is also required to be consistent with our compensation policy. The goals and objectives of Evogene’s office holders are determined
by the compensation and nominating committee and our board of directors. For each fiscal year, our compensation and nominating committee
and board of directors determine the maximum target bonus for each of our office holders, including our CEO. Further, for our CEO, all
terms of employment, including bonus terms, require, in general, approval by a majority of our shareholders present and voting (in person
or by proxy) at a meeting of shareholders, subject to fulfillment of one of the two additional conditions described in “ Item 6.
Directors, Senior Management and Employees - C. Board Practices - Approval of Related Party Transactions under Israeli Law - Disclosure
of Personal Interests of an Office Holder and Approval of Certain Transactions.” As approved by our annual general meeting of shareholders
on August 10, 2021, the annual cash bonus measurable performance objectives of our CEO, Mr. Ofer Haviv may be determined annually by the
Compensation Committee and the Board.

Each of the employment agreements with our executive officers contains
provisions regarding non-competition, confidentiality of information and assignment of inventions. The non-competition provision applies
for a period that is generally 12 months following termination of employment. The enforceability of covenants not to compete in Israel
and in the United States is subject to limitations. The employment agreement of each executive officer is terminable upon between 30 to
90 days’ written notice by either party to the agreement.

83

Director Compensation

Our directors are entitled to cash compensation and equity compensation
as follows:

Cash Compensation